Kynam Capital Management LP's Q3 2022 13F: 4 new positions, 2 exits

Form 13F-HR for the quarter ended Sep 30, 2022 · filed Nov 14, 2022 · 33 reported positions · accession 0001085146-22-004005

What changed this quarter

Kynam Capital Management LP's changes in reported equity positions, Q3 2022
Activity Security Weight before Weight now Change Shares Shares %
Reduced GLOBAL BLOOD THERAPEUTICS IN (GBT) 18.1% 1.9% −16.2 pts −2.07M sh −94%
Increased NATERA INC (NTRA) 11.3% 18.7% +7.4 pts +779K sh +63%
New UNITED THERAPEUTICS CORP DEL (UTHR) — 6.7% +6.7 pts +151K sh new
Reduced GOSSAMER BIO INC (GOSS) 5.1% 1.0% −4.1 pts −1.96M sh −84%
New SANOFI (SNY) — 4.8% +4.8 pts +600K sh new
Reduced TRAVERE THERAPEUTICS INC (TVTX) 7.7% 2.2% −5.6 pts −818K sh −66%
New GSK PLC (GSK) — 3.1% +3.1 pts +500K sh new
Increased CELLDEX THERAPEUTICS INC NEW (CLDX) 7.9% 9.5% +1.6 pts +468K sh +41%
Increased VIRIDIAN THERAPEUTICS INC (VRDN) 1.8% 4.3% +2.6 pts +410K sh +69%
Reduced BIOCRYST PHARMACEUTICALS INC (BCRX) 2.6% 1.2% −1.4 pts −501K sh −54%
Reduced SYNDAX PHARMACEUTICALS INC (SNDX) 12.5% 11.5% −0.9 pts −239K sh −10%
Increased BURNING ROCK BIOTECH LTD (BNR) 3.2% 3.4% +0.2 pts +2.4M sh +56%
Reduced XENON PHARMACEUTICALS INC (XENE) 1.4% 0.2% −1.2 pts −146K sh −84%
Increased CONCERT PHARMACEUTICALS INC (CNCE) 1.1% 2.4% +1.3 pts +673K sh +67%
New PROTAGONIST THERAPEUTICS INC (PTGX) — 0.9% +0.9 pts +519K sh new
Increased SERES THERAPEUTICS INC (MCRB) 0.2% 1.0% +0.8 pts +514K sh +199%
Increased OLEMA PHARMACEUTICALS INC (OLMA) 0.3% 0.8% +0.6 pts +1.15M sh +462%
Increased AMARIN CORP PLC (AMRN) 1.5% 1.5% 0.0 pts +2.71M sh +68%
Exited MERUS N V (MRUS) 0.6% — −0.6 pts −104K sh −100%
Exited FATE THERAPEUTICS INC (FATE) 0.5% — −0.5 pts −81,064 sh −100%
Reduced AMICUS THERAPEUTICS INC (FOLD) 2.5% 1.5% −1.0 pts −223K sh −25%
Increased AKOUOS INC (AKUS) 0.5% 1.0% +0.6 pts +335K sh +87%
Reduced WAVE LIFE SCIENCES LTD (WVE) 1.4% 1.1% −0.4 pts −299K sh −18%
Reduced BIOGEN INC (BIIB) 4.2% 4.2% +0.1 pts −3,951 sh −5%
Increased LIQUIDIA CORPORATION (LQDA) 1.7% 1.9% +0.3 pts +192K sh +13%
Reduced VAXCYTE INC (PCVX) 4.1% 3.5% −0.5 pts −25,143 sh −3%
Increased VERA THERAPEUTICS INC (VERA) 5.3% 6.9% +1.6 pts +13,469 sh +1%
Reduced COGENT BIOSCIENCES INC (COGT) 2.3% 3.1% +0.8 pts −14,845 sh −1%
Reduced CENTESSA PHARMACEUTICALS PLC (CNTA) 1.0% 0.6% −0.3 pts −26,327 sh −3%
Reduced AFFIMED N V (AFMD) 0.5% 0.3% −0.2 pts −24,354 sh −3%
Reduced PUMA BIOTECHNOLOGY INC (PBYI) 0.4% 0.3% −0.1 pts −20,146 sh −3%
Reduced CABALETTA BIO INC (CABA) 0.1% 0.1% −0.1 pts −18,995 sh −3%
Reduced NEOLEUKIN THERAPEUTICS INC (NLTX) 0.0% 0.0% 0.0 pts −4,333 sh −3%
Reduced CATALYST BIOSCIENCES INC (CBIO) 0.0% 0.0% 0.0 pts −3,246 sh −3%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 73.6% of the equity book

Changes in the top 10 this quarter: UTHR entered · SNY entered · VRDN entered · GBT left · TVTX left · GOSS left

# Security Weight before Weight now
1 NATERA INC (NTRA) 11.3% 18.7%
2 SYNDAX PHARMACEUTICALS INC (SNDX) 12.5% 11.5%
3 CELLDEX THERAPEUTICS INC NEW (CLDX) 7.9% 9.5%
4 VERA THERAPEUTICS INC (VERA) 5.3% 6.9%
5 UNITED THERAPEUTICS CORP DEL (UTHR) 0.0% 6.7% Entered the top 10
6 SANOFI (SNY) 0.0% 4.8% Entered the top 10
7 VIRIDIAN THERAPEUTICS INC (VRDN) 1.8% 4.3% Entered the top 10
8 BIOGEN INC (BIIB) 4.2% 4.2%
9 VAXCYTE INC (PCVX) 4.1% 3.5%
10 BURNING ROCK BIOTECH LTD (BNR) 3.2% 3.4%
— GLOBAL BLOOD THERAPEUTICS IN (GBT) 18.1% 1.9% Left the top 10
— TRAVERE THERAPEUTICS INC (TVTX) 7.7% 2.2% Left the top 10
— GOSSAMER BIO INC (GOSS) 5.1% 1.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
Exited CELLDEX THERAPEUTICS INC NEW (CLDX) Call 246K 0 $0
Exited ALNYLAM PHARMACEUTICALS INC (ALNY) Put 50,000 0 $0
New RELMADA THERAPEUTICS INC (RLMD) Put 0 300K $803K
Exited KARUNA THERAPEUTICS INC (KRTX) Put 38,900 0 $0
New TRICIDA INC (TCDAQ) Call 0 260K $338K
New TRICIDA INC (TCDAQ) Put 0 97,600 $122K
New LIQUIDIA CORPORATION (LQDA) Call 0 508K $13K